ELYM
Income statement / Annual
Last year (2024), Eliem Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Eliem Therapeutics, Inc.'s net income was -$73.90 M.
See Eliem Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$14.18 M
|
$15.41 M
|
$26.21 M
|
$23.32 M
|
$9.34 M
|
$4.02 M
|
| General & Administrative Expenses |
$16.03 M
|
$9.89 M
|
$18.92 M
|
$12.35 M
|
$2.43 M
|
$677.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$16.03 M
|
$9.89 M
|
$18.92 M
|
$12.35 M
|
$2.43 M
|
$677.00 K
|
| Other Expenses |
$51.82 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$82.02 M
|
$37.41 M
|
$45.14 M
|
$35.67 M
|
$11.77 M
|
$4.70 M
|
| Cost And Expenses |
$0.00
|
$37.41 M
|
$45.14 M
|
$35.67 M
|
$11.77 M
|
$4.70 M
|
| Interest Income |
$0.00
|
$0.00
|
$1.20 K
|
$450.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$1.59 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$21.47 M
|
$45.14 M
|
$35.67 M
|
$11.77 M
|
$4.70 M
|
| EBITDA |
-$82.02 M |
-$13.65 M |
$1.48 M |
-$35.50 M |
-$2.87 M |
-$1.93 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$8.12 M
|
-$13.65 M
|
-$109.00 K
|
-$11.81 M
|
$257.00 K
|
$899.00 K
|
| Income Before Tax |
-$73.90 M
|
-$35.12 M
|
-$45.24 M
|
-$47.48 M
|
-$20.67 M
|
-$6.55 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$109.00 K
|
$0.00
|
-$9.16 M
|
-$2.75 M
|
| Net Income |
-$73.90 M
|
-$35.12 M
|
-$45.35 M
|
-$47.48 M
|
-$11.51 M
|
-$3.80 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.53 |
-1.3 |
-1.72 |
-1.81 |
-0.44 |
-0.14 |
| EPS Diluted |
-1.53 |
-1.3 |
-1.72 |
-1.81 |
-0.44 |
-0.14 |
| Weighted Average Shares Out |
$67.26 M
|
$26.99 M
|
$26.31 M
|
$26.24 M
|
$26.32 M
|
$26.32 M
|
| Weighted Average Shares Out Diluted |
$67.26 M
|
$26.99 M
|
$26.31 M
|
$26.24 M
|
$26.32 M
|
$26.32 M
|
| Link |
|
|
|
|
|
|
